Skip to main content

Advertisement

Fig. 1 | Breast Cancer Research

Fig. 1

From: Infiltrating stromal immune cells in inflammatory breast cancer are associated with an improved outcome and increased PD-L1 expression

Fig. 1

a Distribution of sTIL scores in the different molecular subtypes (N = 138). Luminal (HR+) 55.1% (N = 76), HER2+ 21.7% (N = 30), TN (HR-Her2−) 23.2% (N = 32). b Distribution of PD-L1 positivity in the categories of sTIL scores (N = 106): 35.8% (N = 38), 51.9% (N = 54), 12.3% (N = 13). There is a strong correlation with PD-L1 immunoreactivity on immune cells (χ2  = 28.9, P < 0.001)

Back to article page